Brought to you by 
Myogen gets license from U.Texas Southwestern Medical Center
27 Feb 2001
Executive Summary
Myogen (molecular approaches to congestive heart failure) has licensed exclusive rights from the University of Texas Southwestern Medical Center. The rights are for discoveries, patents, and future inventions related to heart muscle disease from the university's Dr. Eric Olson and Dr. Stephen R. Grant of the University of North Texas Health Science Center.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Myogen gets license from U.Texas Southwestern Medical Center
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice